Dexamethasone Versus Demedetomidine Addition for Adductor Canal Block

Dexmedetomedine Versus Dexamethasone in Ultrasound Guided Adductor Canal Block for Patients Undergoing Knee Arthroscope

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06527976

Enrollment

Registered

2024-07-30

Start date

2022-02-15

Completion date

2024-01-01

Last updated

2024-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

Single-injection peripheral nerve block (PNB) is commonly used for perioperative analgesia and anesthesia. Three approaches for extending the duration of PNB include continuous PNB with catheter-based techniques, novel local anesthetics delivery systems and addition of novel adjuvants to local anesthetics.

Interventions

DRUGDexmedetomidine

dexmedetomedine added to bupivacaine for adductor canal block

DRUGDexamethasone

dexamethasone added to bupivacaine for adductor canal block

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 60 Years

Healthy volunteers

Inclusion criteria

* elective operation * ASA STATUS I and II

Exclusion criteria

* patient refusal * ASA status III and IV * contraindications to local anesthesia

Design outcomes

Primary

Measure	Time frame	Description
visual analogue scale score	24 hours postoperative	scale of 11 points. zero=no pain, 10 = worest pain ever

Secondary

Measure	Time frame	Description
analgesia duration	24 hours postoperative	pain free duration after block
opioid consumption	24 hours postoperative	amount of opioid consumed postoperative

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026